SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Share News (HVO)

Share Price Information for hVIVO (HVO)

Share Price is delayed by 15 minutes
Get Live Data
8.35    0.05 (0.60%)
Bid:
8.20
Ask:
8.50
Spread: 0.30 (3.659%)
Market Cap: £57.48m
HVO Live PriceLast checked at - London Stock Exchange

Intraday hVIVO Share Chart

hVIVO News

Jupiter Asset Management Takes 11% Holding In hVIVO After Transaction
9 Jul 2019

Jupiter Asset Management Takes 11% Holding In hVIVO After Transaction

(Alliance News) - hVIVO PLC on Tuesday said Jupiter Asset Management Ltd now holds an 11% stake in the scientific research company.Prior to this trans...

UK Shareholder Meetings Calendar - Next 7 Days
23 May 2019

UK Shareholder Meetings Calendar - Next 7 Days

Friday 24 MayPageGroupOld MutualFevertree GroupMonday 27 events 28 Stobart 29

hVIVO Loss Widens On Impairments In Transitional Year
11 Apr 2019

hVIVO Loss Widens On Impairments In Transitional Year

LONDON (Alliance News) - hVIVO PLC on Thursday described 2018 as a "transitional" year as it posted a widened annual loss on impairment charges.For 20...

Positive results from FLU-v study welcomed by hVIVO
10 Jan 2019

Positive results from FLU-v study welcomed by hVIVO

(Sharecast News) - Clinical development services company hVIVO announced positive results for the primary endpoint, following completion of analysis o...

WINNERS & LOSERS SUMMARY: Halfords Drops After Weak Third Quarter
10 Jan 2019

WINNERS & LOSERS SUMMARY: Halfords Drops After Weak Third Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - up 2....

hVIVO Meets Primary Endpoint In Phase II Vaccine Flu Study
10 Jan 2019

hVIVO Meets Primary Endpoint In Phase II Vaccine Flu Study

LONDON (Alliance News) - hVIVO PLC on Thursday said it achieved the primary endpoint in a phase II study of FLU-v, a vaccine candidate for influenza.T...

Mosquito saliva peptide vaccine has hVIVO upbeat
31 Oct 2018

Mosquito saliva peptide vaccine has hVIVO upbeat

(Sharecast News) - Clinical development services business hVIVO confirmed on Wednesday that the National Institutes of Health had presented partial pr...

hVIVO Gets Encouraging Results From Mosquito Disease Vaccine Proposal
31 Oct 2018

hVIVO Gets Encouraging Results From Mosquito Disease Vaccine Proposal

LONDON (Alliance News) - hVIVO PLC said Wednesday preliminary results from the first in-man study of AGS-v, a proposed mosquito-borne disease vaccine,...